212 related articles for article (PubMed ID: 34542745)
1. Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
Pupyshev AB; Tenditnik MV; Ovsyukova MV; Akopyan AA; Dubrovina NI; Tikhonova MA
Bull Exp Biol Med; 2021 Aug; 171(4):425-430. PubMed ID: 34542745
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
4. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
7. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model.
Pupyshev AB; Belichenko VM; Tenditnik MV; Bashirzade AA; Dubrovina NI; Ovsyukova MV; Akopyan AA; Fedoseeva LA; Korolenko TA; Amstislavskaya TG; Tikhonova MA
Pharmacol Biochem Behav; 2022 Jun; 217():173406. PubMed ID: 35609863
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of phenylpropionamides in the seed of Cannabis Sativa L. on Parkinson's disease through autophagy.
Jiang YK; Li MM; Wang SY; Hao ZC; Meng X; Kuang HX; Yang BY; Liu Y
Fitoterapia; 2024 Jun; 175():105883. PubMed ID: 38458497
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation.
Wang L; Tian S; Ruan S; Wei J; Wei S; Chen W; Hu H; Qin W; Li Y; Yuan H; Mao J; Xu Y; Xie J
Free Radic Biol Med; 2024 Apr; 216():60-77. PubMed ID: 38479634
[TBL] [Abstract][Full Text] [Related]
11. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
[TBL] [Abstract][Full Text] [Related]
12. Kaemperfol Protects Dopaminergic Neurons by Promoting mTOR-Mediated Autophagy in Parkinson's Disease Models.
Liu Z; Zhuang W; Cai M; Lv E; Wang Y; Wu Z; Wang H; Fu W
Neurochem Res; 2023 May; 48(5):1395-1411. PubMed ID: 36469163
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.
Liu K; Shi N; Sun Y; Zhang T; Sun X
Neurochem Res; 2013 Jan; 38(1):201-7. PubMed ID: 23117422
[TBL] [Abstract][Full Text] [Related]
14. [Neuroprotective effect of rapamycin against Parkinson's disease in mice].
Zhu F; Fan M; Xu Z; Cai Y; Chen Y; Yu S; Zeng L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):465-472. PubMed ID: 30693687
[TBL] [Abstract][Full Text] [Related]
15. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
16. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.
Jiang TF; Zhang YJ; Zhou HY; Wang HM; Tian LP; Liu J; Ding JQ; Chen SD
J Neuroimmune Pharmacol; 2013 Mar; 8(1):356-69. PubMed ID: 23325107
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.
Siracusa R; Paterniti I; Cordaro M; Crupi R; Bruschetta G; Campolo M; Cuzzocrea S; Esposito E
Mol Neurobiol; 2018 Mar; 55(3):2403-2419. PubMed ID: 28357809
[TBL] [Abstract][Full Text] [Related]
18. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
Bao XQ; Kong XC; Qian C; Zhang D
Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
20. MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease.
Geng L; Gao W; Saiyin H; Li Y; Zeng Y; Zhang Z; Li X; Liu Z; Gao Q; An P; Jiang N; Yu X; Chen X; Li S; Chen L; Lu B; Li A; Chen G; Shen Y; Zhang H; Tian M; Zhang Z; Li J
Mol Neurodegener; 2023 Dec; 18(1):94. PubMed ID: 38041169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
